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Summary. Rats submitted to chronic inhibition of nitric 
oxide synthase (NOS) have developed systemic 
hypertension and consequent renal injury. The present 
study aims to determine glomerular quantitative changes 
due to NOS inhibition in rats. Adults and normotensive 
Wistar rats were separated into control and L-NAME 
groups (each group n=10). The animals received water 
and food ad libitum, while L-NAME rats received N ~ -  
Nitro-L-Arginine methyl Ester hydrochloride to inhibit 
NOS (50mg/kg/day) in drinking water during 40 days. 
After that period the rats were sacrificed, the kidneys 
were removed, measured, and prepared for histological 
and stereological analyses. The glomerular density per 
area [NA(giom)] and the mean glomerular volume [Y] 
were determined per animal in 15 random fields. In L- 
NAME rat the blood pressure was 76% higher than the 
respective control group with the same age. Glomeruli 
had global or segmental glomerular sclerosis; some 
glomeruli only presented an atrophic structure. The renal 
volume was not different between control and L-NAME 
rats (p>0.05). However, L-NAME rats had the NA(giom) 
33% smaller than the control rats (p=0.0001) and, 
concomitantly, L-NAME rats had the Y (glom) 33% 
higher than the control ones (p=0.004). These results 
demonstrate morphological renal alterations caused by 
NOS inhibition and hypertension. 
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lntroduction 
Nitric oxide (NO) is an endothelial endogenous 
vasodilator synthesized by constitutive NO synthase 
(NOS) that has at least three distinct isoforms (Nathan 
and Xie, 1994). NOS catalyses the oxidation of the 
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amino acid L-arginine to give rise to citruline and NO. 
Three or more NOS isoforms are expressed in the 
normal kidney; the brain-type NOS (bNOS) is greatly 
expressed in the macula densa cells and in some adjacent 
thick ascendant limb cells, cells of Bowman's capsule, 
some intrarenal nerves, and tubular structures 
(Bachmann et al., 1995; Zatz and Baylis, 1998). 
A model of systemic hypertension has been 
developed in rats by chronic administration of L- 
Arginine analogues (like ~ ~ - ~ i t r o - ~ - A r ~ i n i n e  Methyl 
Ester or simple L-NAME). The sustained hypertension 
induced by L-NAME involves inhibition of endothelial 
NOS activity. NO may also participate in the control of 
renin secretion by the adjacent juxtaglomerular cells 
(Reid and Chou, 1995) considering that the macula 
densa contains a high concentration of this enzyme 
(Mundel et al., 1992) and that arginine analogues which 
inhibit NOS alter the rate of renin secretrion (Kurtz et 
al. ,  1991;  Johnson and Freeman, 1992). Renal 
endothelial, mesangial and macula densa cells release 
NO, which is involved in the regulation of glomerular 
and medullary microcirculation (Bachmann and Mundel, 
1994). The NO produced within the kidney controls the 
following: glomerular filtration rate, total renal and 
medullary blood flow, pressure natriuresis, epithelial 
sodium transport;  and the production of various 
vasoactive factors including renin, indicating that NO is 
one of the most important systems controlling renal 
function (Kone and Balys, 1997; Madrid et al., 1997). 
The kidney is extremely sensitive to the inhibition of 
NO. Very low doses of L-Arginine analogs, which do not 
affect blood pressure, diminish diuresis, natriuresis and 
renal plasma flow (Nava and Lüscher, 1995). A 
deficiency in the synthesis of NO may contribute to the 
development of systemic hypertension because NO is 
thought to mediate the renal responses to volume 
expansion and in experimental hypertension NO- 
mediated dysfunction has been reported as  partly 
responsible for the impaired pressure natriuresis 
(Ikenaga et al., 1993). 
In conjunction with chronic NOS inhibition, the 
kidney structure shows pathological alterations like 
classic glomerulosclerosis with glomerular accumulation 
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of hyaline material, collapse of capillary loops, and 
adhesion to the parietal layer of Bowman's capsule. The 
glomerular ischemia consists of uniform collapse of the 
glomerular tuft and the capillary loops with pronounced 
thickening and even duplication of the basement 
membrane. Glomerular segmental necrosis appears as 
sharply delimited areas, where lysis of necrotic material 
may result in the formation of microaneurysms. 
Microvascular lesions range between arteriolar wall 
thickening to "onion skin" proliferation with complete 
luminal occlusion, fibrinoid necrosis of the vascular 
wall, and periarteriolar fibrosis. Al1 these renal injury 
types are associated with progressive albuminuria (Zatz 
and Baylis, 1998). 
The chronic inhibition of the NOS in rat induces 
arterial hypertension and renal pathological changes. A 
previous study has shown that chronic inhibition of NOS 
also causes the decrease in intracellular cGMP levels 
(the second messenger of NO) in vascular smooth 
muscle, inducing structural changes of renal 
microvessels (Numaguchi et al., 1995). Othenvise, it is 
speculated that a reduced renal NO synthetic capacity 
may contribute to start or maintain intraglomerular 
hypertension (Baylis et al., 1992). 
The NO-deficient hypertension is associated with the 
attenuation of vascular relaxation and hypercontractility 
in different parts of the vascular tree. The particular 
interest is the reduced relaxation in the renal artery. It 
might result in increased renin release and activation of 
the renin angiotensin system (Bernátová et al., 1996), 
which is recognized as  a factor involved in the 
progression of chronic renal failure and in the 
development of hypertension in renal diseases (Anderson 
et al., 1986; Lai et al., 1988). 
Acute and chronic impairment of NOS or  
endothelial dysfunction may contribute to the initiation 
or perpetuation of hypertension and renal damage in rats 
(Ribeiro et al., 1992; Ono et al., 1995). Tissue injury 
associated with chronic NOS inhibition is not confined 
to the kidney; rats receiving chronic L-NAME treatment 
exhibit focal areas of myocardial necrosis along with 
focal areas of fibrosis that may reflect organization of 
necrotic tissue (Pereira and Mandarim-de-Lacerda, 1998; 
Pereira et al., 1998). Stereology of cardiac microvessels 
revealed remodeling of these vessels in rats under NOS 
inhibition (Pereira and Mandarim-de-Lacerda, 1999). 
Quantification of glomerular structure is considered 
important information to aid the identification of the 
glomerular structural change (Cahill et al., 1996). The 
present study intends to determine stereological 
glomerular parameters in rats submitted to NOS 
inhibition. 
Materials and methods 
Twenty adult male Wistar-strain rats were used in 
this study. Animals weighing 260.8 I 20.lg (mean I 
SD) were kept separate during 40 days in two groups of 
ten animals each. The arterial blood pressure (BP) was 
weekly verified with tail-cuff plethysmography. In the 
c o n t r o l 8 r o u p  the animals received daily food 
(Nuvilab ) and fresh water ad libitum. In the L-NAME 
group animals received L-NAME, 50mg/kg/day ( N ~ -  
Nitro-L-Arginine Methyl Ester Hydrochloride, Sigma 
chemical Co., St Louis, Lot 44H0102) dissolved in 
drinking water. 
This investigation was performed in accordance with 
the Guide for the Care and Use of Laboratory Animals 
published by the US National Institutes of Health (NIH 
Publication No. 85-23, revised 1985), and protocols 
were approved by the animal subjects committee of the 
State University of Rio de Janeiro. 
On the 41st day the animals were anaesthetized and 
sacrificed. Kidneys were removed and weighed 
according to Scherle's method (immersed in 
physiological saline solution) (Scherle, 1970). Since the 
renal tissue is anisotropic, the kidney was cut according 
to the "Orthrip" method (Mattfeldt et al., 1985), i.e. the 
kidney was initially cut at random; the organ was then 
placed on this cut and, again at random, the specimen 
was cut with a perpendicular section to the first plane. 
The specimen was again placed on the new cut surface 
and a new random orientation was defined cutting the 
organ in a perpendicular section to the plane. The last cut 
was considered to be uniformly isotropic: this means that 
without reference to the position of the specimen in the 
first cut the last surface has an orientation which varies 
from al1 possible ones. 
Cortical renal fragments were then immersed in a 
buffered solution of 4% formaldehyde at pH 7.2 for 48- 
72 hours and embedded in paraplastB (Sigma). After 
that, they were sectioned at 5pm thick and stained with 
hematoxylin-eosin, Masson's trichrome, PAS (Schiff's 
reagent) and Gomori's method for reticular fibers (silver 
impregnation). 
The analysis used a video-microscopic system 
composed of a Leica DMRBE microscope coupled to a 
Kappa CF  1515 video camera and a Sony trinitron 
monitor. The numerical density in the plane (glomerular 
profile numerical density per area) [NA(giom)] was 
determined by observing 15  microscopic fields per 
animal, i.e. 150 fields per group (Mandarim-de-Lacerda, 
1998).  Glomeruli were counted in a frame of 
1.31x106,um2, only considering well-preserved structures 
and not crossing the forbidden line (Gundersen, 1977). 
Maximum and minimum glomerular diameters were 
measured on 25 profiles per animal, since the glomerulus 
had been cut near the equatorial region. These diameters 
were measured using final magnification x800. The 
mean glomerular volume [C(glom)] was determined by 
assuming volume of the sphere. 
Differences comparing the groups were tested with 
non-parametric test of Mann-Whitney with significant 
leve1 of 0.05 (Zar, 1999). 
Results 
BP was significantly increased in NOS blockade. 
Glomerular density and volume in rats 
attaining 206.8 2 21.7mmHg (mean 2 SD) after 40 days 
of L-NAME administration, which was 73% higher than 
BP at the beginning of the experiment, and 76% higher 
than BP of the respective control group with the same 
age. The statistical difference in BP between control and 
experimental groups went up from the second week of 
L-NAME administration, continuously increasing until 
the end of the experiment (Fig. 1). 
Figure 2 shows the glomerular morphology in 
control and L-NAME rats. Glomeruli had considerable 
and general alterations in L-NAME rats, characterized 
by global or segmental glomerular sclerosis. Renal 
parenchyma showed some glomeruli, only presenting an 
atrophic structure, tubular atrophy and extensive fibrosis 
(Fig. 2B). Furthermore, in L-NAME rats hypertrophied 
glomeruli had capsular thickening (Figs. 2D,F). 
Quantitative results are summarized in Table 1. The 
renal volume was not different in control and L-NAME 
animals (p>0.05). However, L-NAME rats had the 
N (glom) 33% smaller than the control rats @=0.0001) 
an%, concomitantly, L-NAME rats had the Y (glom) 33% 
higher than the control ones @=0.004). 
Discussion 
This work has induced hypertension in rats using 
50mg/kg/day of L-NAME. After only one week of 
experimentation the differences in blood pressure were 
significant when control and L-NAME rats were 
compared, and these differences were progressively 
accentuated in the weeks that followed. NO is certainly 
released in homeostatic mechanisms to regulate renal 
effects of angiotensin 11 in normotensive rats, and under 
hypertension conditions (Sánchez-Mendoza et al., 1998) 
this mechanism does not function any longer. 
Previous studies using orally active NOS inhibitor in 
different schedules of time and dosage had shown the 
Table l. Results of the quantitative study of the left kidney and the 
glomerular parameters: numerical density per area (NA(g1om)) and 
mean giomeruiar volume (i (glom)). 
GROUPS NA(giom) Y glom VOLUME 
(1/mm2) (mm2) @m3) (left kidney) (mm3) 
Control 
Median 
C195% 
cv % 
CE % 
L-NAME 
Median 
CI 95% 
cv % 
CE % 
CE: coefñcient of error; CI: conñdence inte~al at 95%; CV: coefficient of 
variation; NS: not significant; p: statistical probability (Mann-Whitney 
test). 
development of stable hypertension and glomerulo- 
sclerosis (Baylis et al., 1992) and severe and progressive 
form of hypertension associated with glomerular 
ischemia, glomerulosclerosis and renal interstitial 
expansion (Ribeiro et al., 1992). 
The present study demonstrated that biometrical 
difference (renal volume) does not exist between control 
and L-NAME animals, agreeing with previous studies 
that confirmed no statistical difference in the renal 
weight in spontaneously hypertensive rats (SHR) (Ono et 
al., 1995, 1996) and in Sprague-Dawley rats (D'Arnours 
et al., 1999) with and without L-NAME administration. 
Renal lesions in rats submitted to NOS inhibition 
have been previously described in the literature: Wistar 
(Ribeiro et al., 1992; Bouriquet and Casellas, 1995) and 
SHR-Wistar rats (Ono et al., 1995). The main findings 
are increased mesangial matrix, capillary collapse, 
hyaline deposition, presence of segmental fibrinoid 
necrosis of the glomerular tuft, and adhesion of the 
glomerular tuft to Bowman's capsule. The arteries and 
arterioles revealed moderate to marked hypertrophy in 
the media with hyaline deposition. 
Agreeing with these previous studies the present 
quantitative approach detected injury of the entire 
nephron population caused by L-NAME administration 
with severe morphological lesions of glomeruli and 
simultaneous increase of the glomerular volume in the 
reminiscent glomeruli. Present results agree with 
previous descriptions reporting that the diminished renal 
NO formation could play a role in the hemodynamic and 
non-hemodynarnic abnormalities reported in the model 
of extreme renal ablation that precedes and eventually 
leads to the development of glomerulosclerosis and renal 
scarring (Aiello et al., 1997; Ichihara et al., 1998). 
The responses of glomerular cells to injury and 
resulting architectural changes of the glomerulus such as 
mesangial hypertrophy, mesangial hyperplasia, and 
increased mesangial cell matrix production are often due 
Flg. 1. Bar graph of lhe variation of the arteriel Eail preeaure comparing 
Control and L-NAME groups regarding time in weeks of L-MAME 
administration. Asterisks show statistically significant differences 
(p<0.05). 
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Flg. 2. Photomicrographs of the renal 
cortex in rats of the Control and L- 
NAME groups, same magnification (in 
Fig F, bar: 50pm). A. Control group, 
normal glomerulus, Masson stain. B. L- 
NAME group, disorganized architecture 
showing a deteriorated glomerulus, 
dilated tubules and extensive fibrosis, 
Masson stain. C. Control group, two 
normal glomeruli and tubules, PAS 
stain. D. L-NAME group, hypertrophied 
glomeruli showing hypercellularity, 
thrombi in glomerular capillaries 
characteristic of microangiopathic 
disorder, thickening of the capillary 
walls, mesangial proliferation and matrix 
increase, PAS stain. E. Control group, 
two normal glomeruli, silver 
impregnation. F. L-NAME group, 
hypertrophied glomeruli with glomerular 
capsule thickening, silver impregnation. 
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to the added effects of hemodynamic (glomerular 
hypertension) and nonhemodynamic actions of the 
vasoactive agents, much as occurred in systemic vascular 
beds (Gibbons and Dzau, 1994; Raij, 1998). 
However, D'Amours and co-workers (1999) 
studying the effects of the NOS inhibition in Sprague- 
Dawley rats, found no difference in the body, heart and 
kidney weights comparing control and L-NAME 
animals, no difference was either found in the number of 
glomeruli between these two groups of animals. They 
concluded, even recognizing that their findings are in 
contrast to other studies reporting that L-NAME-induced 
hypertension causes renal damage, that NOS inhibitor 
caused severe hypertension without renal damage. This 
discrepancy is difficult to explain, but D'Amours and co- 
workers (1999) suggest that it may be due to a number of 
experimental factors, including rat strain, age, and the 
duration of the treatment. 
Most studies on glomerular size consider glomerulus 
a sphere. Even so a more accurate approximation would 
be to consider it a slightly prolate or oblate ellipsoid. 
However, the first assumption is reasonable because the 
relationship between volume and mean axial values does 
not vary considerably between the latter solids and 
spheres (Pesce, 1998). In the present study the 
appearance of the glomeruli was relatively uniform 
among the animals of the same group allowing expecting 
that the biases are similar in both control and L-NAME 
groups. Furthermore, the sampling of only well 
preserved glomerular profiles in control and L-NAME 
groups may cause a biased determination, which is, 
however, comparable in both groups. If clearly injured 
structures had been included in the analysis it would 
have been impossible to compare normal kidneys with 
the ones having alteration due to NO inhibition, but that 
was not the case of the present study. 
Apoptosis has been observed in the glomerular cells 
of experimental nephritis (Shimizu et al., 1995) and 
human proliferative glomerulonephritis (Sugiyama et al., 
1996). Apoptosis has been considered a major 
mechanism for the resolution of glomerular 
hypercellularity in the recovery of glomerulonephritis, 
controlling the size of the glomerular population and 
clearing excess cells (Baker et al., 1994; Shimizu et al., 
1995; Davis and Ryan, 1998) and it is responsible for the 
progressive cell loss occurring in the pathogenesis of 
glomerular sclerosis (Davis and Ryan, 1998). In L- 
NAME animals of the present study we observed 
glomerular sclerosis and some glomeruli presenting an 
atrophic structure, tubular atrophy and extensive fibrosis. 
We have considered the small, round nuclei in the 
glomeruli as morphological evidence of apoptosis, but 
the use of an immunolabelling technique is  stil l  
necessary to confirm this evidence. According to Hattori 
and co-workers (1998) an increase in the extracellular 
matrix, which accumulates in parallel with a decrease in 
the number of glomerular cells, is related to apoptosis 
that subsequently causes the decrease in renal function. 
However, these authors have considered the role of 
apoptosis in the depletion of glomerular cells still 
controversia1 and that new studies are required. 
In summary, the present study submitted Wistar rats 
to a chronic NOS inhibition that provoked arteria1 
hypertension and renal morphological lesions. The 
quantitative information about glomerular changes in 
experimental animals showed alterations in the number 
and in the volume of the glomeruli but not in the entire 
renal volume. Further investigation is required to clarify 
the detailed mechanisms underlying the progression of 
the renal lesions in this experimental model. 
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